About NeuroPace, Inc. 
NeuroPace, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 28 Schemes (14.07%)
Foreign Institutions
Held by 36 Foreign Institutions (34.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
22 Million
(Quarterly Results - Mar 2026)
Net Profit:
-7 Million
Pharmaceuticals & Biotechnology
USD 449 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.00
-110.24%
23.58






